2015
DOI: 10.1002/phar.1633
|View full text |Cite
|
Sign up to set email alerts
|

Evaluation of a Community Pharmacy–Based Screening Questionnaire to Identify Patients at Risk for Drug Therapy Problems

Abstract: The screening questionnaire was a reliable method for identifying patients in community pharmacies who have a large number of DTPs.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
19
0

Year Published

2016
2016
2022
2022

Publication Types

Select...
6

Relationship

2
4

Authors

Journals

citations
Cited by 7 publications
(19 citation statements)
references
References 19 publications
0
19
0
Order By: Relevance
“…[6][7][8] Despite this work, DTPs are not typically classified with a severity score. Previous studies have evaluated predictors for total number of DTPs, 10,11 with one considering the severity of the DTPs as low, moderate, or severe. 10 Quintana-Bárcena developed a validated process to rate severity of DTPs in chronic kidney disease patients in community pharmacies based on interventions required to manage DTPs, but is not generalizable due to limitations of contextual design and population.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…[6][7][8] Despite this work, DTPs are not typically classified with a severity score. Previous studies have evaluated predictors for total number of DTPs, 10,11 with one considering the severity of the DTPs as low, moderate, or severe. 10 Quintana-Bárcena developed a validated process to rate severity of DTPs in chronic kidney disease patients in community pharmacies based on interventions required to manage DTPs, but is not generalizable due to limitations of contextual design and population.…”
Section: Introductionmentioning
confidence: 99%
“…Previous studies have evaluated predictors for total number of DTPs, 10,11 with one considering the severity of the DTPs as low, moderate, or severe. 10 Quintana-Bárcena developed a validated process to rate severity of DTPs in chronic kidney disease patients in community pharmacies based on interventions required to manage DTPs, but is not generalizable due to limitations of contextual design and population. 12 Dean and Barber created a validated tool to assess severity of medication errors using a 1 to 10 scale, as assessed by various health care professionals, but it is not clear if this can be applied more broadly to DTP severity.…”
Section: Introductionmentioning
confidence: 99%
“…We strongly advocate using an evidence-based screening tool such as a Medication Risk Assessment Questionnaire (MRAQ) to help identify patients who may benefit from pharmacist consultation. 3,4…”
Section: Resultsmentioning
confidence: 99%
“…We strongly advocate using an evidence-based screening tool such as a Medication Risk Assessment Questionnaire (MRAQ) to help identify patients who may benefit from pharmacist consultation. 3,4 Recommendation 6: Be highly visible and accessible The simple, but invaluable, concept that the guidelines refer to as "strategic loitering" highlights one way to remain visible and accessible to other PCPs. For example, many PCPs in Chilliwack frequent the physicians' lounge at the hospital-many physicians emphasized this location as the most impactful site for strategic loitering in the whole city.…”
Section: Recommendation 4: Educate Yourself About the Roles Of The Otmentioning
confidence: 99%
“…However, increasingly, short questionnaires are being used to enable risk identification for public health intervention, 14 to inform the pharmacist about patient’s medicines taking and tailor their intervention accordingly, 12 and, when combined with the patient medication record, to determine the need for drug-related intervention. 15 …”
Section: Patient Medication Recordsmentioning
confidence: 99%